Novel targets, treatments, and advanced models for intracerebral haemorrhage
Marietta Zille(Institute of Pharmacology), Johannes Boltze(Fraunhofer Institute for Cell Therapy and Immunology), Tracy D. Farr(University of Nottingham), Richard F. Keep(University of Michigan), Guohua Xi(University of Michigan), Christine Römer(Institute of Clinical and Experimental Medicine)
Cited by 165
Related Papers
Neuronal Death After Hemorrhagic Stroke In Vitro and In Vivo Shares Features of Ferroptosis and Necroptosis
|Stroke|2017|514
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial
|The Lancet Neurology|2019|249
Spontaneous white matter damage, cognitive decline and neuroinflammation in middle-aged hypertensive rats: an animal model of early-stage cerebral small vessel disease
|Acta Neuropathologica Communications|2014|215
The IMPROVE Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments)
|Journal of Cerebral Blood Flow & Metabolism|2017|203
Introduction to the Blood-Brain Barrier
|Cambridge University Press eBooks|1998|182